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A B S T R A C T
Background: Although the degree of electroanatomical remodeling of the left atrium (LA) is inﬂuenced by
left ventricular (LV) diastolic function, clinical implications of estimated LV ﬁlling pressure (E/Em) are
limited in patients with atrial ﬁbrillation (AF). We hypothesized that increased E/Em is related to an
advanced LA remodeling, a high CHA2DS2-VASc score, and the presence of stroke or transient ischemic
attack (TIA) in patients with paroxysmal AF.
Methods: We included 1098 patients with paroxysmal AF (male 74.5%, 57.6  11.3 years old) who
underwent AF catheter ablation. We compared E/Em to clinical parameters, echocardiography, and three-
dimensional-computed tomography ﬁndings.
Results: The E/Em > 15 group (n = 98) was older (p < 0.001) and had more females (p < 0.001), greater
LA volume index (p < 0.001), higher CHA2DS2-VASc score (p < 0.001), and stroke/TIA prevalence
(p = 0.001) than groups with an E/Em of 8–15 (n = 676) or <8 (n = 324). An E/Em was independently
associated with the presence of stroke/TIA (OR 1.638, 95% CI 1.050–2.554, p = 0.030) after adjusting for
age, sex, body surface area, LA volume index, and LA appendage volume index.
Conclusions: In patients with paroxysmal AF, the elevated LV ﬁlling pressure estimated by E/Em is
independently associated with the presence of stroke or TIA.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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The prevalence of heart failure with preserved ejection fraction
(HFpEF) is frequently correlated with atrial ﬁbrillation (AF) [1]. The
onset of AF triggers HFpEF in patients with subclinical left
ventricular (LV) diastolic dysfunction and may predispose to a
poorer prognosis in patients with heart failure [2,3]. There has
been a growing interest in understanding a mechanical linkage
between diastolic dysfunction and AF with particular attention to
the complex interaction between the left atrium (LA) and the LV
during diastole [4]. The ratio of early diastolic mitral inﬂow
velocity (E) to early diastolic mitral annular velocity (Em) has been
used to assess LV ﬁlling pressure, and an E/Em > 15 usually
indicates pulmonary capillary wedge pressure > 20 mmHg [5]. The* Corresponding author at: 50 Yonseiro, Seodaemun-gu, Seoul 120-752, Republic
of Korea. Tel.: +82 2 2228 8459; fax: +82 2 393 2041.
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http://dx.doi.org/10.1016/j.jjcc.2015.10.008
0914-5087/ 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rightscorrelation of E/Em with pulmonary capillary wedge pressure has
been found in patients with AF as well as in sinus rhythm [5–
8]. Moreover, the prognostic signiﬁcance of LV ﬁlling pressure
estimated by E/Em is well recognized in different clinical settings
and populations including heart failure and non-valvular AF
[9,10]. We recently reported that LA appendage (LAA) function is
closely related to E/Em and the degree of electroanatomical
remodeling of LA in patients with paroxysmal AF [11,12]. Although
Kosiuk et al. [13] reported a relationship between LV diastolic
dysfunction and risk of stroke in 124 patients with AF as a brief
report, no other study showed systemic analyses for the
relationship between LV diastolic function and risk of stroke in
a larger number of patients with AF. Therefore, we hypothesized
that LV ﬁlling pressure estimated by E/Em is associated with
advanced LA remodeling and the risk of events of stroke in patients
with paroxysmal AF. The purpose of this study was to evaluate the
relationships among E/Em, LA remodeling, CHA2DS2-VASc score,
and the presence of stroke or transient ischemic attack (TIA) in
patients with paroxysmal AF. reserved.
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Patient selection
The study protocol adhered to the Declaration of Helsinki and
was approved by the Institutional Review Board of Yonsei
University Health System. The study enrolled 1098 consecutive
patients (74.5% of who were male, 57.6  11.3 years old) who
underwent pre-procedural transthoracic echocardiography (TTE) and
transesophageal echocardiography (TEE), and radiofrequency cathe-
ter ablation (RFCA) for symptomatic drug-refractory paroxysmal AF.
The exclusion criteria for RFCA were as follows: (1) persistent or
permanent AF; (2) any mitral valve disease, including mild-degree
disease; (3) AF with rheumatic valvular disease; (4) associated
structural heart disease other than left ventricular hypertrophy; and
(5) prior AF ablation. All patients provided proper written informed
consent. A total of 1098 patients were selected for the study, and then
were categorized into three groups based on their E/Em measured
with TTE and Doppler study. We compared the patient groups of
E/Em > 15 (n = 98), E/Em 8–15 (n = 676), and E/Em < 8 (n = 324)
according to the recommendation of the European Society of
Cardiology [14]. The prevalence of stroke was deﬁned as a history
of focal neurologic deﬁcit with acute onset and lasting for more than
24 hours with positive results on neuroimaging studies, and TIA was
deﬁned as sudden-onset focal neurologic symptoms or signs that
resolved within 24 hours [15].
Echocardiographic and computed tomographic evaluation of the heart
TTE was conducted using commercially available devices (iE33,
Philips Medical System, Andover, MA, USA; Vivid 7 or Vivid E9, GE
Vingmed Ultrasound, Horten, Norway), and standard M-mode, 2-
dimensional, and Doppler images were acquired in the parasternal
and apical views. The 2-dimensional images were acquired to
calculate the following characteristics: LV end-diastolic dimen-
sion, LV end-systolic dimension, posterior wall thickness at end
diastole, interventricular septal wall thickness at end diastole, and
LV ejection fraction. LV mass and LV mass index were calculated
using American Society of Echocardiography (ASE)-recom-
mended formula, area length method [16]. The value of early
mitral inﬂow peak velocity (E) was taken by placing sample
volume at the opening level of the mitral valve leaﬂet tips based on
the pulse wave Doppler method. Tissue Doppler-derived early
diastolic mitral annular velocity (Em) was collected from the
septal corner of the mitral annulus in the apical four-chamber
view. TEE was performed to measure pulmonary vein ﬂow
velocity as well as LAA emptying ﬂow velocity. 3-dimensional
spiral computed tomography (64 Channel, Light Speed Volume Ct,
Philips, Brilliance 63, Amsterdam, Netherlands) was performed on
all patients.
Electrophysiological mapping and radiofrequency catheter ablation
Intracardiac electrograms were recorded using the Prucka
Cardio LabTM electrophysiology system (General Electric Medical
Systems Inc., Milwaukee, WI, USA). A 3D electroanatomical map
(NavX, St. Jude Medical Inc., Minnetonka, MN, USA) was generated
by merging NavX system-generated 3D geometry of the LA and
pulmonary veins with corresponding 3D spiral CT images. Using a
multi-polar ring catheter (Lasso, Johnson & Johnson Inc, Diamond
Bar, CA, USA), a 3D LA voltage map was generated from contact
bipolar electrograms of 350–500 points on the LA endocardium
during high RA pacing (pacing cycle length 500 ms). The bipolar
electrograms were ﬁltered at 32–300 Hz. Color-coded voltage
maps were generated by recording bipolar electrograms and
measuring peak-to-peak voltage as previously described[17]. However, when frequently re-initiating AF required more
than 3 electrical cardioversions, the LA voltage map was not
constructed. In the end, 759 of the 1098 patients had a complete set
of LA and LAA voltage data.
Data analyses
Statistical analyses were performed using SPSS (Statistical
Package for Social Sciences, Chicago, IL, USA) software for Windows
(version 20.0). Continuous variables were expressed as the
mean  standard deviation (SD) and compared using Student’s
t-tests and ANOVAs followed by post hoc analyses using Bonferroni’s
method. Categorical variables were reported as frequencies (percent-
age) and compared using Chi-square tests or Fisher’s exact tests. To
conﬁrm the association between E/Em ratio and the presence of
stroke/TIA and/or CHA2DS2-VASc score >2 after controlling potential
confounding variables, we used multiple logistic regression analyses.
A p-value <0.05 was regarded as statistically signiﬁcant.
Results
E/Em and the degree of LA remodeling
Table 1 summarizes the clinical characteristics in each grade of
E/Em. The patients in the E/Em > 15 group had an older age
(p < 0.001), a higher proportion of females (p < 0.001), a lower
body surface area (p < 0.001), and a higher CHA2DS2-VASc score
(p < 0.001). They were also more likely to have congestive heart
failure (p < 0.001), hypertension (p < 0.001), diabetes mellitus
(p = 0.004), and a history of stroke or TIA (p < 0.001) than those with
a low E/Em. Remarkably, nearly 20% of patients with
E/Em > 15 reported a history of stroke/TIA. When the E/Em > 15,
E/Em 8–15, and E/Em <8 groups were compared to each other using
post hoc analyses, the patients with level of E/Em > 15 had greater
LA volume index (p < 0.001), LA dimension (p < 0.001), and LV mass
index (p < 0.001), and lower LAA emptying ﬂow velocity (p < 0.001)
than other groups. Fig. 1 displays the exemplary LA electroanato-
mical voltage maps and LAA emptying ﬂow velocity depending on
the E/Em.
E/Em and presence of stroke/TIA
Fig. 2 shows the relationships of LA volume index (p < 0.001),
LV mass index (p < 0.001), LAA emptying ﬂow velocity (p < 0.001),
LAA volume index (p < 0.001), and E/Em (p < 0.001) depending on
CHA2DS2-VASc scores. Table 2 presents the logistic regression
analyses for clinical and electroanatomical variables associated
with the presence of stroke/TIA. In the univariate logistic
regression analyses, the presence of stroke/TIA was associated
with old age (p < 0.001), lesser body surface area (p = 0.020),
higher E/Em (p < 0.001), as well as greater LA volume index
(p < 0.001) and LAA volume index (p = 0.002), and lower LAA
emptying ﬂow velocity (p < 0.001). In the multivariate logistic
regression analyses, an E/Em was independently associated with
the presence of stroke/TIA (OR 1.638, 95% CI 1.050–2.554,
p = 0.030) after adjusting for age, sex, body surface area, LA
volume index, and LAA volume index. We performed the logistic
regression analyses for clinical and anatomical variables associated
with CHA2DS2-VASc scores (>2, n = 269; 1–2, n = 509; and 0,
n = 320), and compared 114 patients with a history of stroke/TIA
and 984 patients without one in supplementary tables.
Discussion
This is the ﬁrst systemic analysis for the relationship of LV
diastolic function with LA remodeling, and risk or presence of
Table 1
Clinical, electroanatomical, and echocardiographic parameters depending on E/Em.
All subjects (n = 1098) E/Em > 15 (n = 98) E/Em 8–15 (n = 676) E/Em  8 (n = 324) p-value
Age (years) 57.64  11.33 64.83  9.31*,y 59.17  10.69z 52.30  11.05 <0.001
Female gender (%) 280 (25.5) 50 (51.0) 189 (28.0) 41 (12.7) <0.001
Body mass index (kg/m2) 24.70  2.85 24.81  2.73 24.86  2.88z 24.33  2.79 0.021
Body surface area (m2) 1.80  0.18 1.70  0.16*,y 1.80  0.18z 1.85  0.17 <0.001
AF duration (months) 40.92  54.58 37.50  30.30 44.51  58.35 36.79  54.27 0.840
CHA2DS2-VASc score 1.59  1.55 2.77  1.83*,y 1.74  1.55z 0.92  1.12 <0.001
CHF (%) 50 (4.6) 16 (16.3) 25 (3.7) 9 (2.8) <0.001
Hypertension (%) 499 (45.4) 62 (63.3) 334 (49.4) 103 (31.8) <0.001
Age >75 (%) 68 (6.2) 12 (12.2) 50 (7.4) 6 (1.9) <0.001
Diabetes mellitus (%) 134 (12.2) 21 (21.4) 84 (12.4) 29 (9.0) 0.004
Stroke/TIA (%) 114 (10.4) 18 (18.4) 78 (11.5) 18 (5.6) <0.001
Vascular disease (%) 162 (14.8) 25 (25.5) 108 (16.0) 29 (9.0) <0.001
Medications
ACEI/ARB (%) 357 (32.5) 48 (49.0) 237 (35.1) 72 (22.2) <0.001
b-Blocker (%) 345 (31.4) 40 (40.8) 207 (30.7) 98 (30.2) 0.111
Statin (%) 301 (27.4) 37 (37.8) 205 (30.4) 59 (18.2) <0.001
AAD (%) 59 (5.4%) 8 (8.2%) 38 (5.6%) 13 (4.0%) 0.251
3D-CT & voltage map
LA volume index(mL/m2) 73.19  20.77 86.85  24.87*,y 73.46  20.89z 68.38  16.89 <0.001
LAA volume index (mL/m2) 6.34  2.95 6.55  2.83 6.47  3.08 5.99  2.68 0.082
Mean LA voltage (mV) 1.35  0.65 1.23  0.65 1.34  0.64 1.39  0.67 0.195
LAA voltage (mV) 2.51  1.56 2.11  1.28 2.58  1.58 2.50  1.55 0.068
TTE
LA dimension (mm) 39.71  5.57 43.00  5.61*,y 40.16  5.50z 37.80  5.06 <0.001
LV mass index, (g/m2) 92.42  21.13 105.81  26.46*,y 93.78  20.62z 85.64  17.67 <0.001
LVEF (%) 63.88  8.00 63.80  11.43 64.09  8.13 63.45  6.29 0.494
E velocity (m/s) 0.73  0.67 0.85  0.22y 0.77  0.79z 0.61  0.47 <0.001
DT (ms) 190.98  43.49 197.53  52.26 189.83  42.53 191.30  42.40 0.276
Em velocity (cm/s) 7.41  2.36 4.61  1.34*,y 6.99  1.83z 9.17  2.38 <0.001
Sm velocity (cm/s) 6.75  1.56 5.75  1.34*,y 6.59  1.50z 7.37  1.51 <0.001
E/Em 10.40  5.03 – – – –
Sinus rhythm during TTE 791 (72.0%) 79 (80.6%) 472 (69.8%) 240 (74.1%) 0.053
A velocity (m/s) 0.58  0.19 0.67  0.24*,y 0.61  0.19z 0.47  0.13 <0.001
E/A ratio 1.28  0.64 1.36  0.55 1.25  0.68 1.32  0.55 0.196
TEE
LAA-FV (cm/s) 57.14  20.70 44.88  20.33*,y 56.90  20.64z 62.05  19.10 <0.001
PV-FV systolic/diastolic 1.28  0.50 1.20  0.57 1.26  0.49 1.33  0.50 0.152
p-values <0.05 were marked as bold.
AAD, antiarrhythmic drug; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin type II receptor blocker; A velocity, late diastolic mitral inﬂow peak velocity
during atrial contraction; CHF, congestive heart failure; E velocity, early diastolic mitral inﬂow peak velocity; Em velocity, early diastolic mitral annulus (septal area) peak
velocity; EF, ejection fraction; DT, deceleration time: time from peak E velocity to decline to baseline; LA, left atrium; LAA, LA appendage; LAA-FV, LA appendage ﬂow
velocity; LV, left ventricle; Sm velocity, mitral annular septal area peak systolic velocity; TEE, trans-esophageal echocardiography; TIA, transient ischemic attack; TTE,
trans-thoracic echocardiography; PV-FV systolic/diastolic, systolic/diastolic ratio of pulmonary vein ﬂow velocity.
* p < 0.05, E/Em > 15 vs. E/Em 8–15 by post hoc analyses using Bonferroni’s method.
y p < 0.05, E/Em > 15 vs. E/Em  8 by post hoc analyses using Bonferroni’s method.
z p < 0.05, E/Em 8–15 vs. E/Em  8 by post hoc analyses using Bonferroni’s method.
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with paroxysmal AF. The present study demonstrates that high LV
ﬁlling pressure estimated by E/Em is related to the structural
remodeling of LA and LAA emptying ﬂow velocity, and is
independently associated with the presence of stroke/TIA in patients
with paroxysmal AF. These ﬁndings suggest that the reason for the
increased thromboembolic risk in patients with AF is not the simple
immobilization of LAA, but a combination of mechanisms and inter-
relationships between multiple risk factors of stroke, LV ﬁlling
pressure, LA remodeling, and LAA function. Therefore, systemic
understanding of AF and more comprehensive approaches are
required for the prevention of ischemic stroke in patients with AF.
The association between high LV ﬁlling pressure and history of
ischemic stroke in AF
AF is characterized by the loss of mechanical atrial function due
to asynchronous LA contraction, inability to augment LV ﬁlling, and
highly variable cycle lengths. All these factors complicate diastolic
function assessment in AF. Although the conventional Doppler
echocardiographic assessment of transmitral ﬂow and pulmonary
vein ﬂow indices can be utilized in analyzing the LV diastolic ﬁllingpattern, it cannot be applied readily in the absence of atrial
waveform during AF [6,18]. However, the relationship between E/
Em and LV ﬁlling pressure has been validated in patients with AF
[2,6]. Our present study showed that E/Em was signiﬁcantly
associated with atrial remodeling and a history of stroke or TIA in
over 1000 patients with paroxysmal AF. This relationship may be
explained with the deleterious effect of raised LV ﬁlling pressure on
LA pressure and volume overload as well as that of stretching-
induced atrial ﬁbrotic changes on the reduction of LA compliance
and function [19]. In a sub-analysis of patients with a CHA2DS2-VASc
score 2, an E/Em was not associated with the presence of stroke or
TIA (OR 1.236, 95% CI 0.584–2.616, p = 0.579). Therefore, the risk of
stroke in patients with AF needs to be understood in terms of long-
term systemic changes associated with hemodynamic stress and
advanced remodeling, especially in patients with higher stroke risk.
LV diastolic dysfunction, LA remodeling and comorbidities
Consistent with our study, many studies have reported the
associations of LV diastolic dysfunction with hypertension, arterial
stiffness, or diabetes [20,21]. These risk factors, all of which are
included in CHA2DS2-VASc score, can cause LA remodeling and
Fig. 1. (A) Anterior views of color-coded left atrial voltage maps (reconstructed three-dimensional spiral computed tomography image) depending on the degree of E/Em. (B)
Doppler images matching the electro-anatomical maps. A velocity, late diastolic mitral inﬂow peak velocity during atrial contraction; E velocity, early diastolic mitral inﬂow
peak velocity; Em (E0) velocity, early diastolic mitral annulus (septal area) peak velocity; DT (deceleration time), time from peak E velocity to decline to baseline; LAA-FV, left
atrial appendage ﬂow velocity; TDI, Tissue Doppler Imaging (septal area).
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dysfunction has a signiﬁcant cause-and-effect relationship with
stroke events or whether the two are simply associated, and
whether an improvement in LV diastolic dysfunction and LAFig. 2. A comparison of echo-Doppler parameters between groups of different CHA2DS
method. LAA-FV, left atrial appendage ﬂow velocity; LA, left atrial; LV, left ventricular.reverse remodeling reduces stroke risk or not. Moreover, LV
diastolic dysfunction could have adverse effects on clinical
outcome after catheter ablation for AF [23]. Therefore, prospective
clinical studies for stroke incidence in relation to the improvement2-VASc scores. *p-values were calculated by post hoc analyses using Bonferroni’s
Table 2
Univariate and multivariate logistic regression analyses for the presence of stroke/
TIA.
Stroke/TIA Univariate analyses
OR 95% CI p-value
Age (years) 1.056 1.035–1.077 <0.001
Female 1.275 0.832–1.953 0.264
Body surface area (m2) 0.266 0.087–0.810 0.020
Body mass index (kg/m2) 0.962 0.898–1.032 0.278
3D-CT
LA volume index (mL/m2) 1.023 1.012–1.034 <0.001
LAA volume index (mL/m2) 1.112 1.039–1.190 0.002
TTE
LA dimension (mm) 1.079 1.043–1.117 <0.001
LV mass index, (g/m2) 1.006 0.997–1.016 0.180
LVEF (%) 0.980 0.959–1.003 0.082
E velocity (m/s) 1.013 0.767–1.336 0.929
Em velocity (cm/s) 0.899 0.825–0.980 0.015
Sm velocity (cm/s) 0.741 0.647–0.849 <0.001
E/Em 1.968 1.404–2.759 <0.001
TEE
LAA-FV (cm/s) 0.968 0.957–0.980 <0.001
PV-FV Systolic/diastolic 0.782 0.468–1.306 0.348
Stroke/TIA Multivariate analyses
OR 95% CI p-value
Model 1
E/Em 1.535 1.063–2.216 0.022
Model 2
E/Em 1.594 1.027–2.476 0.038
Model 3
E/Em 1.638 1.050–2.554 0.030
Model 4
E/Em 1.427 0.860–2.367 0.169
p-values <0.05 were marked as bold.
E/Em was analyzed as categorical variable (E/Em > 15, E/Em 8–15, and
E/Em < 8).
Model 1; Adjusted for age, sex, and body surface area.
Model 2; Adjusted for independent variables in model 1 and LA volume index.
Model 3; Adjusted for independent variables in model 2 and LAA volume index.
Model 4; Adjusted for independent variables in model 3, Sm velocity, and LAA-FV.
E velocity, early diastolic mitral inﬂow peak velocity; Em velocity, early diastolic
mitral annulus (septal area) peak velocity; EF, ejection fraction; LA, left atrium;
LAA, LA appendage; LAA-FV, LA appendage ﬂow velocity; LV, left ventricle; Sm
velocity, mitral annular septal area peak systolic velocity; TEE, trans-esophageal
echocardiography; TIA, transient ischemic attack; TTE, trans-thoracic echocardi-
ography; PV-FV systolic/diastolic, systolic/diastolic ratio of pulmonary vein ﬂow
velocity.
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understanding the mechanism of stroke in patients with AF.
Limitations
Given that this study was a single center cohort study that
included a highly selected group of paroxysmal AF patients
referred for catheter ablation, the ﬁndings cannot be generalized to
all types of AF within the general population. It remains to be
elucidated whether elevated LV ﬁlling pressure has a signiﬁcant
cause-and-effect relationship with stroke events. A study with
prospective design is warranted to determine whether a change in
E/Em reduces the incidence of stroke.
Conclusion
LV ﬁlling pressure estimated by E/Em is related to the structural
remodeling of LA and LAA emptying ﬂow velocity, and indepen-
dently associated with high risk of stroke represented by high
CHA2DS2-VASc score and the presence of stroke/TIA in patients
with paroxysmal AF.Disclosures
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